Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
106783562 | 10678356 | 2 | F | 20160803 | 20141223 | 20160813 | EXP | US-INDICUS PHARMA-000284 | INDICUS | HAROON N, RAZA SM, BHAT ZY. HYPOMAGNESEMIA AND CHEMOTHERAPY, DIAGNOSTIC DILEMMA, AND TREATMENT CHALLENGE: CASE REPORT AND LITERATURE REVIEW. AM J THER. 2014 DEC 1. | 63.00 | YR | F | Y | 0.00000 | 20160813 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
106783562 | 10678356 | 1 | PS | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | U | 79148 | |||||||||||
106783562 | 10678356 | 2 | SS | AVASTIN | BEVACIZUMAB | 1 | N | 0 | |||||||||||
106783562 | 10678356 | 3 | SS | IRINOTECAN | IRINOTECAN | 1 | 6 CYCLES | N | 0 | ||||||||||
106783562 | 10678356 | 4 | SS | XELODA | CAPECITABINE | 1 | U | 0 | |||||||||||
106783562 | 10678356 | 5 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | N | 0 | |||||||||||
106783562 | 10678356 | 6 | SS | FOLINIC ACID | LEUCOVORIN | 1 | N | 0 | |||||||||||
106783562 | 10678356 | 7 | SS | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | U | 0 | |||||||||||
106783562 | 10678356 | 8 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | 0 | ||||||||||||
106783562 | 10678356 | 9 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | 0 | ||||||||||||
106783562 | 10678356 | 10 | C | MECLIZINE | MECLIZINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
106783562 | 10678356 | 11 | C | ZOLPIDEM | ZOLPIDEMOLPIDEM TARTRATE | 1 | 0 | ||||||||||||
106783562 | 10678356 | 12 | C | ERGOCALCIFEROL. | ERGOCALCIFEROL | 1 | 0 | ||||||||||||
106783562 | 10678356 | 13 | C | AMITRIPTYLINE | AMITRIPTYLINE | 1 | 0 | ||||||||||||
106783562 | 10678356 | 14 | C | HYDROCODONE | HYDROCODONE | 1 | 0 | ||||||||||||
106783562 | 10678356 | 15 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | 0 | ||||||||||||
106783562 | 10678356 | 16 | C | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
106783562 | 10678356 | 17 | C | LORAZEPAM. | LORAZEPAM | 1 | 0 | ||||||||||||
106783562 | 10678356 | 18 | C | METOPROLOL. | METOPROLOL | 1 | 0 | ||||||||||||
106783562 | 10678356 | 19 | C | LOPERAMIDE | LOPERAMIDE | 1 | 0 | ||||||||||||
106783562 | 10678356 | 20 | C | CELECOXIB. | CELECOXIB | 1 | 0 | ||||||||||||
106783562 | 10678356 | 21 | C | BENADRYL | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
106783562 | 10678356 | 1 | Product used for unknown indication |
106783562 | 10678356 | 2 | Colon cancer metastatic |
106783562 | 10678356 | 3 | Colon cancer metastatic |
106783562 | 10678356 | 4 | Colon cancer metastatic |
106783562 | 10678356 | 5 | Colon cancer metastatic |
106783562 | 10678356 | 6 | Colon cancer metastatic |
106783562 | 10678356 | 7 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
106783562 | 10678356 | HO |
106783562 | 10678356 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
106783562 | 10678356 | Alopecia | |
106783562 | 10678356 | Diarrhoea | |
106783562 | 10678356 | Hypomagnesaemia | |
106783562 | 10678356 | Malabsorption |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
106783562 | 10678356 | 2 | 201210 | 0 | ||
106783562 | 10678356 | 3 | 201105 | 0 | ||
106783562 | 10678356 | 5 | 201105 | 0 | ||
106783562 | 10678356 | 6 | 201105 | 0 |